{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:11:38Z","timestamp":1793261498866,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":2149,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1186\/s13613-020-0628-2","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:02:55Z","timestamp":1579690975000},"page":"9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Vasopressin and its analogues in shock states: a review"],"prefix":"10.1016","volume":"10","author":[{"given":"Julien","family":"Demiselle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Fage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Radermacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1175-9149","authenticated-orcid":false,"given":"Pierre","family":"Asfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1186\/s13613-020-0628-2_bb0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1113\/jphysiol.1895.sp000565","article-title":"On the physiological action of extracts of pituitary body and certain other glandular organs: preliminary communication","volume":"18","author":"Oliver","year":"1895","journal-title":"J Physiol (Lond)."},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ki.1976.76","article-title":"The osmoregulation of vasopressin","volume":"10","author":"Robertson","year":"1976","journal-title":"Kidney Int"},{"issue":"12","key":"10.1186\/s13613-020-0628-2_bb0020","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1172\/JCI107521","article-title":"The role of blood osmolality and volume in regulating vasopressin secretion in the rat","volume":"52","author":"Dunn","year":"1973","journal-title":"J Clin Invest."},{"issue":"4","key":"10.1186\/s13613-020-0628-2_bb0025","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1152\/physrev.1983.63.4.1243","article-title":"Central nervous system mediators of vasopressin release","volume":"63","author":"Sklar","year":"1983","journal-title":"Physiol Rev"},{"issue":"10","key":"10.1186\/s13613-020-0628-2_bb0030","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1043-2760(00)00304-0","article-title":"Vasopressin receptors","volume":"11","author":"Birnbaumer","year":"2000","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.1975.tb00521.x","article-title":"Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs","volume":"30","author":"Mannucci","year":"1975","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1186\/s13613-020-0628-2_bb0040","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1152\/ajplegacy.1972.223.4.958","article-title":"Aggregation of human blood platelets by vasopressin","volume":"223","author":"Haslam","year":"1972","journal-title":"Am J Physiol"},{"key":"10.1186\/s13613-020-0628-2_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yfrne.2017.10.004","article-title":"Cross-talk among oxytocin and arginine-vasopressin receptors: relevance for basic and clinical studies of the brain and periphery","volume":"51","author":"Song","year":"2018","journal-title":"Front Neuroendocrinol"},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0950-351X(96)80314-4","article-title":"Vasopressin and oxytocin receptors","volume":"10","author":"Zingg","year":"1996","journal-title":"Baillieres Clin Endocrinol Metab"},{"issue":"2","key":"10.1186\/s13613-020-0628-2_bb0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/hep.510270206","article-title":"Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension","volume":"27","author":"Bernadich","year":"1998","journal-title":"Hepatology"},{"issue":"2","key":"10.1186\/s13613-020-0628-2_bb0060","first-page":"141","article-title":"Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches","volume":"18","author":"Chernow","year":"1986","journal-title":"Circ Shock."},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13054-018-1967-3","article-title":"Vasoplegia treatments: the past, the present, and the future","volume":"22","author":"Levy","year":"2018","journal-title":"Crit Care"},{"issue":"5","key":"10.1186\/s13613-020-0628-2_bb0070","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1186\/s13613-020-0628-2_bb0075","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ajem.2005.02.055","article-title":"Low plasma vasopressin\/norepinephrine ratio predicts septic shock","volume":"23","author":"Lin","year":"2005","journal-title":"Am J Emerg Med."},{"issue":"6","key":"10.1186\/s13613-020-0628-2_bb0080","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","article-title":"Circulating vasopressin levels in septic shock","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1186\/s13613-020-0628-2_bb0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003246-200203000-00001","article-title":"Depletion of neurohypophyseal content of vasopressin in septic shock","volume":"30","author":"Sharshar","year":"2002","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1186\/s13613-020-0628-2_bb0090","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00003246-199708000-00012","article-title":"Vasopressin pressor hypersensitivity in vasodilatory septic shock","volume":"25","author":"Landry","year":"1997","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1186\/s13613-020-0628-2_bb0095","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00000658-198004000-00017","article-title":"Mechanisms of impaired cardiac function by vasopressin","volume":"191","author":"Wilson","year":"1980","journal-title":"Ann Surg"},{"issue":"6","key":"10.1186\/s13613-020-0628-2_bb0100","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1213\/01.ANE.0000087039.60041.2E","article-title":"The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock","volume":"97","author":"Martikainen","year":"2003","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1186\/s13613-020-0628-2_bb0105","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.RES.76.3.418","article-title":"Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats","volume":"76","author":"Avontuur","year":"1995","journal-title":"Circ Res"},{"issue":"2","key":"10.1186\/s13613-020-0628-2_bb0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00134-002-1546-5","article-title":"Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport","volume":"29","author":"Westphal","year":"2003","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1186\/s13613-020-0628-2_bb0115","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.CCM.0000128578.37822.F1","article-title":"Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock","volume":"32","author":"Malay","year":"2004","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00003246-200301000-00033","article-title":"Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats","volume":"31","author":"Asfar","year":"2003","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1186\/s13613-020-0628-2_bb0125","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/cc7959","article-title":"Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial","volume":"13","author":"Simon","year":"2009","journal-title":"Crit Care"},{"issue":"4","key":"10.1186\/s13613-020-0628-2_bb0130","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00134-003-2094-3","article-title":"Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock","volume":"30","author":"Morelli","year":"2004","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1186\/s13613-020-0628-2_bb0135","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s001340101014","article-title":"The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series","volume":"27","author":"Holmes","year":"2001","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1186\/s13613-020-0628-2_bb0140","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","article-title":"Beneficial effects of short-term vasopressin infusion during severe septic shock","volume":"96","author":"Patel","year":"2002","journal-title":"Anesthesiology"},{"issue":"18","key":"10.1186\/s13613-020-0628-2_bb0145","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study","volume":"107","author":"D\u00fcnser","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1186\/s13613-020-0628-2_bb0150","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/cc12789","article-title":"Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine","volume":"17","author":"Mehta","year":"2013","journal-title":"Crit Care"},{"issue":"2","key":"10.1186\/s13613-020-0628-2_bb0155","first-page":"351","article-title":"Impact of vasopressin analogues on the gut mucosal microcirculation","volume":"22","author":"Asfar","year":"2008","journal-title":"Best Pract Res Clin Anaesthesiol."},{"issue":"2","key":"10.1186\/s13613-020-0628-2_bb0160","first-page":"148","article-title":"The effects of vasopressin and its analogues on the liver and its disorders in the critically ill","volume":"16","author":"Asfar","year":"2010","journal-title":"Curr Opin Crit Care."},{"issue":"2","key":"10.1186\/s13613-020-0628-2_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.CCM.0000152253.45901.FB","article-title":"Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism","volume":"33","author":"Asfar","year":"2005","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1186\/s13613-020-0628-2_bb0170","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1097\/01.CCM.0000094260.05266.F4","article-title":"High-dose vasopressin is not superior to norepinephrine in septic shock","volume":"31","author":"Klinzing","year":"2003","journal-title":"Crit Care Med"},{"issue":"2 Pt 2","key":"10.1186\/s13613-020-0628-2_bb0175","first-page":"F274","article-title":"Renal microvascular effects of vasopressin and vasopressin antagonists","volume":"256","author":"Edwards","year":"1989","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1186\/s13613-020-0628-2_bb0180","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000159082","article-title":"Arginine vasopressin-induced renal vasodilation mediated by nitric oxide","volume":"32","author":"Rudichenko","year":"1995","journal-title":"J Vasc Res"},{"issue":"5","key":"10.1186\/s13613-020-0628-2_bb0185","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.CCM.0000059722.94182.79","article-title":"Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors","volume":"31","author":"D\u00fcnser","year":"2003","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1186\/s13613-020-0628-2_bb0190","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1186\/s13613-020-0628-2_bb0195","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1476-5381.2011.01776.x","article-title":"Inotropes and vasopressors: more than haemodynamics!","volume":"165","author":"Bracht","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1186\/s13613-020-0628-2_bb0200","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/CCM.0000000000002323","article-title":"The septic shock 3.0 definition and trials: a vasopressin and septic shock trial experience*","volume":"45","author":"Russell","year":"2017","journal-title":"Critical Care Med"},{"issue":"3","key":"10.1186\/s13613-020-0628-2_bb0205","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","article-title":"Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock","volume":"37","author":"Russell","year":"2009","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","article-title":"The effects of vasopressin on acute kidney injury in septic shock","volume":"36","author":"Gordon","year":"2010","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1186\/s13613-020-0628-2_bb0215","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Acute Dialysis Quality Initiative workgroup","year":"2004","journal-title":"Crit Care."},{"issue":"5","key":"10.1186\/s13613-020-0628-2_bb0220","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13613-018-0449-8","article-title":"Hemodynamic support in the early phase of septic shock: a review of challenges and unanswered questions","volume":"8","author":"Lesur","year":"2018","journal-title":"Ann Intensive Care."},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13613-018-0379-5","article-title":"Predictors of response to fixed-dose vasopressin in adult patients with septic shock","volume":"8","author":"Sacha","year":"2018","journal-title":"Ann Intensive Care."},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0235","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jss.2015.07.016","article-title":"Effects of terlipressin on patients with sepsis via improving tissue blood flow","volume":"200","author":"Xiao","year":"2016","journal-title":"J Surg Res"},{"issue":"11","key":"10.1186\/s13613-020-0628-2_bb0240","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s00134-018-5267-9","article-title":"Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial","volume":"44","author":"Study Group of investigators","year":"2018","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CCM.0000000000001380","article-title":"A selective V1A receptor agonist, selepressin, is superior to arginine vasopressin and to norepinephrine in ovine septic shock*","volume":"44","author":"He","year":"2016","journal-title":"Critical Care Med"},{"issue":"7","key":"10.1186\/s13613-020-0628-2_bb0250","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1097\/CCM.0000000000000300","article-title":"The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*","volume":"42","author":"Maybauer","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-020-0628-2_bb0255","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.14607","article-title":"Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial","author":"Laterre","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-019-2362-4","article-title":"The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis","volume":"23","author":"Jiang","year":"2019","journal-title":"Crit Care"},{"issue":"6","key":"10.1186\/s13613-020-0628-2_bb0265","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials","volume":"45","author":"Nagendran","year":"2019","journal-title":"Intensive Care Med"},{"issue":"18","key":"10.1186\/s13613-020-0628-2_bb0270","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology."},{"issue":"3","key":"10.1186\/s13613-020-0628-2_bb0280","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13613-019-0498-7","article-title":"Current use of vasopressors in septic shock","volume":"9","author":"Scheeren","year":"2019","journal-title":"Anna Intensive Care."},{"issue":"1","key":"10.1186\/s13613-020-0628-2_bb0290","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/CCM.0000000000001441","article-title":"Selepressin in septic shock: a step toward decatecholaminization?","volume":"44","author":"Asfar","year":"2016","journal-title":"Crit Care Med"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-020-0628-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13613-020-0628-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025010490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025010490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-020-0628-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:42:57Z","timestamp":1776670977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025010490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["S2110582025010490"],"URL":"https:\/\/doi.org\/10.1186\/s13613-020-0628-2","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasopressin and its analogues in shock states: a review","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-020-0628-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The Author(s) 2020. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"9"}}